0001790058-23-000001.txt : 20230804 0001790058-23-000001.hdr.sgml : 20230804 20230804150432 ACCESSION NUMBER: 0001790058-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230804 DATE AS OF CHANGE: 20230804 EFFECTIVENESS DATE: 20230804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MediSix Therapeutics, Inc. CENTRAL INDEX KEY: 0001790058 IRS NUMBER: 842859845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-395539 FILM NUMBER: 231143624 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET, SUITE 1380 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-933-3770 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET, SUITE 1380 CITY: BOSTON STATE: MA ZIP: 02116 D/A 1 primary_doc.xml X0708 D/A LIVE 0001790058 MediSix Therapeutics, Inc. 500 BOYLSTON STREET, SUITE 1380 BOSTON MA MASSACHUSETTS 02116 617-933-3770 DELAWARE None None Corporation true 2019 Michael Carusi 500 Boylston Street, Suite 1380 BOSTON MA MASSACHUSETTS 02116 Director George A. Poste 500 Boylston Street, Suite 1380 BOSTON MA MASSACHUSETTS 02116 Director William Harrington 500 Boylston Street, Suite 1380 BOSTON MA MASSACHUSETTS 02116 Director Andrew R. Bruce 500 Boylston Street, Suite 1380 BOSTON MA MASSACHUSETTS 02116 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001713695-21-000001 2021-04-01 false true true false 0 22500000 22500000 0 false 5 0 0 0 false MediSix Therapeutics, Inc. Andrew Bruce Andrew Bruce President 2023-08-04